Crossmark

CRISPR-based therapeutic genome editing for inherited blood disorders

Crossref DOI link: https://doi.org/10.1038/s41573-025-01236-y

Published Online: 2025-07-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Levesque, Sébastien

Bauer, Daniel E. https://orcid.org/0000-0001-5076-7945
License Information

Text and Data Mining valid from 2025-07-14

Version of Record valid from 2025-07-14
More Information

Article History

Accepted: 3 June 2025

First Online: 14 July 2025

Competing interests

: S.L. and D.E.B. are inventors on patent applications related to therapeutic genome editing.